In-line monitoring and interpretation of an indomethacin anti-solvent crystallization process by near-infrared spectroscopy (NIRS).
暂无分享,去创建一个
Woo-Sik Kim | Young-Sang Cho | Myung-Yung Jeong | Min-Jeong Lee | Min-Jeong Lee | Hea-Eun Lee | Woo-Sik Kim | Myung-Yung Jeong | G. Choi | Hea-Eun Lee | Guang Jin Choi | Young‐Sang Cho
[1] E. Yonemochi,et al. Solid-state 13C NMR study of indomethacin polymorphism. , 2006, International journal of pharmaceutics.
[2] R. E. Marsh,et al. Crystal and molecular structure of an antiinflammatory agent, indomethacin, 1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid. , 1972, Journal of the American Chemical Society.
[3] Effect of Supersaturation on Crystal Size and Number of Crystals Produced in Antisolvent Crystallization , 2002 .
[4] M. Kitamura,et al. Anti-solvent crystallization and transformation of thiazole-derivative polymorphs—I: effect of addition rate and initial concentrations , 2003 .
[5] G. Witkamp,et al. Some antisolvents for crystallisation of sodium carbonate , 1999 .
[6] W. Beckmann. Nucleation phenomena during the crystallisation and precipitation of Abecarnil , 1999 .
[7] Å. Rasmuson,et al. Size and morphology of benzoic acid crystals produced by drowning-out crystallisation , 1999 .
[8] H. Takiyama,et al. Morphology of NaCl Crystals in Drowning-Out Precipitation Operation , 1998 .
[9] K. Urakami,et al. A novel method for estimation of transition temperature for polymorphic pairs in pharmaceuticals using heat of solution and solubility data. , 2002, Chemical & pharmaceutical bulletin.
[10] Thomas Rades,et al. Quantifying ternary mixtures of different solid-state forms of indomethacin by Raman and near-infrared spectroscopy. , 2007, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[11] Y. Ozaki,et al. Comparative determination of polymorphs of indomethacin in powders and tablets by chemometrical near-infrared spectroscopy and X-ray powder diffractometry , 2003, AAPS PharmSciTech.
[12] E. Risley,et al. ANTI-INFLAMMATORY AND ANTIPYRETIC ACTIVITIES OF INDOMETHACIN, 1-(P-CHLOROBENZOYL)-5-METHOXY-2-METHYLINDOLE-3-ACETIC ACID. , 1963, The Journal of pharmacology and experimental therapeutics.
[13] R. Liu. Water-insoluble drug formulation , 2000 .
[14] B. Glennon,et al. The Effect of Mixing on the Metastable Zone Width and Nucleation Kinetics in the Anti-Solvent Crystallization of Benzoic Acid , 2007 .
[15] K. Morris,et al. Reactivity differences of indomethacin solid forms with ammonia gas. , 2002, Journal of the American Chemical Society.
[16] T. Rades,et al. Physical characterization and stability of amorphous indomethacin and ranitidine hydrochloride binary systems prepared by mechanical activation. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[17] N. Kaneniwa,et al. Physicochemical characterization of indomethacin polymorphs and the transformation kinetics in ethanol. , 1985, Chemical & pharmaceutical bulletin.
[18] J. Sherwood,et al. Morphological evaluation of the γ-polymorph of indomethacin , 2002 .
[19] Pui Shan Chow,et al. Effects of operating conditions on agglomeration and habit of paracetamol crystals in anti-solvent crystallization , 2005 .
[20] K. Johnston,et al. Investigation of processing parameters of spray freezing into liquid to prepare polyethylene glycol polymeric particles for drug delivery , 2008, AAPS PharmSciTech.